VI Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

VI Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 12, 2022	Design Pharmaceuticals	$5.0M Pre-Series A	Tianhong Xu	—
Aug 28, 2019	HiFiBiO	$67.0M Series C	IDG Capital	Delian Capital, Hanne Capital, Hongshan Capital Group (Sequoia Capital China), Kite, LYFE Capital
Dec 4, 2018	Viracta Therapeutics	$10.0M Other Equity	Kevin Ye	Forward Ventures, Latterell Venture Partners, NantKwest
Dec 3, 2018	Tactiva Therapeutics	$35.0M Series A	Panacea Healthcare Partners	Efung Capital
Aug 8, 2018	Apexigen	$73.0M Series B / Series C	Karen Liu, Dan Zabrowski, SV Tech Ventures, VI Ventures	—
May 16, 2018	HiFiBiO	$37.5M Series B	Lynn Yang, James Zhao	Nest.Bio Ventures, Proxima Ventures
May 14, 2018	Ansun BioPharma	$85.0M Series A	Lilly Asia Ventures, Sinopharm Capital	3E Bioventures Capital, Joincap Investment, LYFE Capital, Matrix Partners China, Oceanpine Capital, YuanMing Capital
Jun 9, 2017	Platelet BioGenesis	$10.0M Series A	Qiming Venture Partners USA	Adena Partners, eCoast Angels, Edgar G. Engleman
Apr 1, 2017	Epic Sciences	$40.0M Series D	Jerry Xiao	Deerfield Management, Domain Associates, Altos Capital Partners, Frederic Pla, Pagoda Investment, Reach Tone Limited, RusnanoMedInvest, Sabby Capital
Jun 6, 2016	Applied StemCell	$19.0M Series D	Jerry Xiao	BioSciKin, Jiang Zhang